343 related articles for article (PubMed ID: 18518848)
1. Genetic polymorphism analysis of CYP2C19 in Chinese Han populations from different geographic areas of mainland China.
Chen L; Qin S; Xie J; Tang J; Yang L; Shen W; Zhao X; Du J; He G; Feng G; He L; Xing Q
Pharmacogenomics; 2008 Jun; 9(6):691-702. PubMed ID: 18518848
[TBL] [Abstract][Full Text] [Related]
2. Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations.
Yin SJ; Ni YB; Wang SM; Wang X; Lou YQ; Zhang GL
J Clin Pharm Ther; 2012 Jun; 37(3):364-9. PubMed ID: 21913948
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese.
Zhou Q; Yu XM; Lin HB; Wang L; Yun QZ; Hu SN; Wang DM
Pharmacogenomics J; 2009 Dec; 9(6):380-94. PubMed ID: 19636337
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population.
Hu LM; Dai DP; Hu GX; Yang JF; Xu RA; Yang LP; Qian JC; Ge RS; Cai JP
Pharmacogenomics; 2012 Nov; 13(14):1571-81. PubMed ID: 23148634
[TBL] [Abstract][Full Text] [Related]
5. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations.
Wang SM; Zhu AP; Li D; Wang Z; Zhang P; Zhang GL
J Hum Genet; 2009 Jun; 54(6):372-5. PubMed ID: 19444287
[TBL] [Abstract][Full Text] [Related]
6. Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China.
Qin S; Shen L; Zhang A; Xie J; Shen W; Chen L; Tang J; Xiong Y; Yang L; Shi Y; Feng G; He L; Xing Q
Genomics; 2008 Sep; 92(3):152-8. PubMed ID: 18632250
[TBL] [Abstract][Full Text] [Related]
7. Genetic variations and haplotypes of CYP2C19 in a Japanese population.
Fukushima-Uesaka H; Saito Y; Maekawa K; Ozawa S; Hasegawa R; Kajio H; Kuzuya N; Yasuda K; Kawamoto M; Kamatani N; Suzuki K; Yanagawa T; Tohkin M; Sawada J
Drug Metab Pharmacokinet; 2005 Aug; 20(4):300-7. PubMed ID: 16141610
[TBL] [Abstract][Full Text] [Related]
8. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
Zuo LJ; Guo T; Xia DY; Jia LH
Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
Zuo J; Xia D; Jia L; Guo T
Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
[TBL] [Abstract][Full Text] [Related]
10. Cyp2c19 genotype and omeprazole hydroxylation phenotype in Chinese Li population.
Wang JH; Li PQ; Fu QY; Li QX; Cai WW
Clin Exp Pharmacol Physiol; 2007; 34(5-6):421-4. PubMed ID: 17439410
[TBL] [Abstract][Full Text] [Related]
11. Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population.
Ma Y; Ni W; Zhu W; Xiong Y; Deng X
Blood Press; 2011 Jun; 20(3):166-70. PubMed ID: 21332417
[TBL] [Abstract][Full Text] [Related]
12. Distribution of CYP2C19*17 allele and genotypes in an Indian population.
Anichavezhi D; Chakradhara Rao US; Shewade DG; Krishnamoorthy R; Adithan C
J Clin Pharm Ther; 2012 Jun; 37(3):313-8. PubMed ID: 21916910
[TBL] [Abstract][Full Text] [Related]
13. A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China.
Xiong Y; Wang M; Fang K; Xing Q; Feng G; Shen L; He L; Qin S
Genomics; 2011 May; 97(5):277-81. PubMed ID: 21126569
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphism analysis of cytochrome P4502C19 in Chinese Uigur and Han populations.
Niu CY; Luo JY; Hao ZM
Chin J Dig Dis; 2004; 5(2):76-80. PubMed ID: 15612662
[TBL] [Abstract][Full Text] [Related]
15. Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2.
Si D; Wang J; Zhang Y; Zhong D; Zhou H
Biopharm Drug Dispos; 2012 Sep; 33(6):342-5. PubMed ID: 22886551
[TBL] [Abstract][Full Text] [Related]
16. Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles.
Kim KA; Song WK; Kim KR; Park JY
J Clin Pharm Ther; 2010 Dec; 35(6):697-703. PubMed ID: 21054462
[TBL] [Abstract][Full Text] [Related]
17. Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese.
Maekawa K; Fukushima-Uesaka H; Tohkin M; Hasegawa R; Kajio H; Kuzuya N; Yasuda K; Kawamoto M; Kamatani N; Suzuki K; Yanagawa T; Saito Y; Sawada J
Pharmacogenet Genomics; 2006 Jul; 16(7):497-514. PubMed ID: 16788382
[TBL] [Abstract][Full Text] [Related]
18. Comparisons of CYP2C19 genetic polymorphisms between Korean and Vietnamese populations.
Lee SS; Lee SJ; Gwak J; Jung HJ; Thi-Le H; Song IS; Kim EY; Shin JG
Ther Drug Monit; 2007 Aug; 29(4):455-9. PubMed ID: 17667801
[TBL] [Abstract][Full Text] [Related]
19. CYP2C19 genetic polymorphism in Thai, Burmese and Karen populations.
Tassaneeyakul W; Mahatthanatrakul W; Niwatananun K; Na-Bangchang K; Tawalee A; Krikreangsak N; Cykleng U; Tassaneeyakul W
Drug Metab Pharmacokinet; 2006 Aug; 21(4):286-90. PubMed ID: 16946555
[TBL] [Abstract][Full Text] [Related]
20. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2002 Jun; 53(6):596-603. PubMed ID: 12047484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
